Organizational Readiness And Barriers To Adoption Of Female External Urinary Devices In Hospitals

June 14, 2026 updated by: Mohamed Fakhry Ahmed Salem, Alexandria University

Organizational Readiness And Barriers To The Adoption Of Female External Urinary Collection Devices: A Multicenter Mixed-Methods Study In Resource-Constrained Healthcare Settings

This study aims to assess organizational readiness and explore perceived barriers and facilitators influencing the adoption of female external urinary collection devices among nurses in healthcare settings. Using a mixed-methods approach, the study examines individual, organizational, and contextual factors that may impact implementation.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Alexandria, Egypt, 21511
        • Faculty of Nursing, Alexandria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population includes registered nurses, staff nurses, and head nurses working in clinical settings across participating healthcare facilities. Participants are involved in direct patient care in units such as intensive care, medical, and surgical wards.

Description

Inclusion Criteria:

  • Registered nurses, staff nurses, or head nurses
  • Currently working in clinical settings (e.g., ICU, medical, or surgical units)
  • Direct involvement in patient care
  • Willing to participate and provide informed consent

Exclusion Criteria:

  • Nurses on extended leave during the data collection period
  • Incomplete questionnaire responses

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Nurses in Participating Healthcare Facilities
Other: Exposure to Female External Urinary Collection Device Concept
Participants were provided with a brief standardized explanation and visual description of female external urinary collection devices prior to completing the study questionnaire. This was done to ensure a consistent baseline understanding of the device concept across participants. No clinical intervention or device application was performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Organizational Readiness for Implementing Female External Urinary Collection Devices
Time Frame: Time Frame: Immediately after questionnaire completion
Measured using the Organizational Readiness for Implementing Change (ORIC) scale (12 items, Likert scale 1-5).
Time Frame: Immediately after questionnaire completion
Perceived Barriers and Facilitators to Adoption of Female External Urinary Collection Devices
Time Frame: Time Frame: Immediately after questionnaire completion
Measured using the adapted Measurement Instrument for Determinants of Innovations (MIDI) (Likert scale 1-5), covering innovation, user, organizational, and contextual determinants.
Time Frame: Immediately after questionnaire completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Alexandria University

Investigators

  • Principal Investigator: Mohamed Fakhry Ahmed Salem, PhD in Medical-Surgical Nursin, Alexandria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 18, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 15, 2026

Study Registration Dates

First Submitted

June 14, 2026

First Submitted That Met QC Criteria

June 14, 2026

First Posted (Actual)

June 18, 2026

Study Record Updates

Last Update Posted (Actual)

June 18, 2026

Last Update Submitted That Met QC Criteria

June 14, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • FEUCD-ORIC-MIDI-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthcare Technology Adoption

Clinical Trials on Exposure to Female External Urinary Collection Device Concept

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe